WEBINAR SERIES—Cardiovascular Disease in Polycystic Ovarian Syndrome

December 11, 2024
11 a.m. EST

Watch On-demand

In this webinar, Licy Yanes Cardozo, MD, presents the heightened cardiovascular risks in people with polycystic ovarian syndrome (PCOS). Topics will include the mechanisms underlying these risks, current treatments available, potential new therapies and the existing knowledge gaps in women’s health research.

Key Learning Objectives

• Review the cardiovascular risk factors associated with hyperandrogenemia in people with PCOS.
• Identify critical mechanisms underlying the cardiovascular risk factors in people with PCOS.
• Describe the current therapeutic agents available in the clinic to treat cardiovascular risk factors in people with PCOS.
• Discuss novel therapeutic agents that could treat cardiovascular disease in people with PCOS
• Identify knowledge gaps in women’s health research.

Speaker

Licy Yanes Cardozo, MD
Professor, Cell and Molecular Biology and Medicine, University of Mississippi Medical Center

Licy L. Yanes Cardozo, MD, is a professor in the Departments of Pharmacology and Medicine/Endocrinology at the University of Mississippi Medical Center (UMMC). She received her MD and completed her residency in internal medicine at the National University of Asuncion in Paraguay. Yanes Cardozo’s postdoctoral studies, under the mentorship of Jane Reckelhoff, PhD, FAPS, in the Department of Physiology at UMMC, explored the mechanisms by which androgens regulate blood pressure. After she become an assistant professor in physiology, Yanes Cardozo joined UMMC’s Department of Medicine, completing a residency in internal medicine and a fellowship in endocrinology.

She is a physician-scientist and practicing endocrinologist engaged in basic and clinical research focused on how androgen excess mediates cardiovascular disease in women.